Evolving medical and surgical management of infants with trisomy 18
Authors:
- George E. HardartGHGeorge E. Hardart
- 1 April 2014
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Pediatrics
- Vol. 26 (2) , 169-176
Abstract
To review the evolving management of infants/children with trisomy 18, the prognosis with and without medical intervention, the factors that have contributed to the evolving management strategies, and an approach to the formulation of healthcare management plans for newborns with trisomy 18. There has been a trend from nonintervention for infants/children with trisomy 18 toward management to prolong life. It has become clear that the prognosis for infants/children with trisomy 18 is not as 'hopeless' as was once asserted. However, case series of patients with trisomy 18 managed with a goal of prolonging life are not adequate to evaluate the efficacy of these interventions. They are also not adequate to support the contention that they have no efficacy. In fact, anecdotal evidence and medical plausibility suggest that treatment can prolong life in some cases. This trend has been supported by a change in emphasis from a largely physician-directed model of medical decision-making to a collaborative model, which respects parents' rights to make healthcare decisions for their children and recognizes that judgments about outcomes are often subjective, and social networks, which support and advocate for children with trisomy 18 and their families. An approach to collaborative medical decision-making that is goal-directed is recommended. Healthcare management approaches or policies that reject out of hand the goal of prolonging the life of any infant/child with trisomy 18 are not defensible. Management plans should be goal-directed, based on the physician-parent evaluation of the benefits and burdens of care options for the individual child.Keywords
This publication has 37 references indexed in Scilit:
- Trisomy 18 and hypertrophy cardiomyopathy in an 18‐year‐old womanAmerican Journal of Medical Genetics Part A, 2008
- Congenital malformations among liveborn infants with trisomies 18 and 13American Journal of Medical Genetics Part A, 2006
- Trisomy 18 in neonates: prenatal diagnosis, clinical features, therapeutic dilemmas and outcomeJournal of Applied Genetics, 2006
- Effectiveness of cardiac surgery in trisomies 13 and 18 (from the Pediatric Cardiac Care Consortium)The American Journal of Cardiology, 2004
- Natural history of trisomy 18 and trisomy 13: I. Growth, physical assessment, medical histories, survival, and recurrence riskAmerican Journal of Medical Genetics, 1994
- Survival in trisomy 18American Journal of Medical Genetics, 1994
- Rates and survival of individuals with trisomy 13 and 18 Data from a 10‐year period in DenmarkClinical Genetics, 1988
- Changing demography of trisomy 18.Archives of Disease in Childhood, 1986
- Survival in trisomy 18: Life tables for use in genetic counselling and clinical paediatricsClinical Genetics, 1985
- Who will survive with trisomy 13 or 18? A call for cases 10 years old or aboveAmerican Journal of Medical Genetics, 1981